The CUSATM (Cavitron Corporation - Stamford, Conn., USA) has been used for aspiration and ultrasonic fragmentation in 52 cases of intracranial tumors: 24 meningiomas, 20 gliomas, 5 acoustic neurinomas, 1 cerebral metastasis, 1 pinealoma, 1 pituitary adenoma in our Clinic, since January 1979. Several advantages of the CUSA were found as compared to conventional techniques: it provides good visibility of the operating field: pathologic tissue can be removed from the surface to the deep structures and only one instrument is present in the surgical cavity; its use reduces manipulation, traction and thermic effects on nearby tissue; it selectively spares major vessels and has a hemostatic effect on those less than 1 mm in diameter. The rapidity of the action of the CUSA is relative to the consistency of the tissue. Tumors of high consistency are very slowly removed by the CUSA, and its use is not worthwhile. In our cases no damage to the surrounding structures was evident. Preliminary experimental data suggest that the use of the CUSA be avoided near the brain stem or within the spinal cord. However, in a cervical ependymoma of our series, the CUSA provided complete removal of the mass without complications. This result was achieved by using lower vibratory power: we were thus able to remove pathologic soft tissue without clinically evident damage to the surrounding structures. In some particular situations the volume and the shape of the instrument can be a hindrance, and some modifications are suggested: a bayonet shape and longer tip would facilitate the reaching of deep structures and permit its use in transphenoidal surgery; incorporation of a cautery in the tip, so that contemporary hemostasis can be accomplished. Our experience indicates that the use in transphenoidal surgery; incorporation of a cautery in the tip, so that contemporary hemostasis can be accomplished. Our experience indicates that the use of the CUSA is better indicated in deep tumors: meningiomas of the base of the skull, acoustic neurinomas, pinealomas, pituitary adenomas. In gliomas it is very useful in the selective removal of the neoplastic tissue in functionally important areas.
Ultrasonic aspiration in the surgical treatment of intracranial tumors.
ZEME, Sergio Mario;
1981-01-01
Abstract
The CUSATM (Cavitron Corporation - Stamford, Conn., USA) has been used for aspiration and ultrasonic fragmentation in 52 cases of intracranial tumors: 24 meningiomas, 20 gliomas, 5 acoustic neurinomas, 1 cerebral metastasis, 1 pinealoma, 1 pituitary adenoma in our Clinic, since January 1979. Several advantages of the CUSA were found as compared to conventional techniques: it provides good visibility of the operating field: pathologic tissue can be removed from the surface to the deep structures and only one instrument is present in the surgical cavity; its use reduces manipulation, traction and thermic effects on nearby tissue; it selectively spares major vessels and has a hemostatic effect on those less than 1 mm in diameter. The rapidity of the action of the CUSA is relative to the consistency of the tissue. Tumors of high consistency are very slowly removed by the CUSA, and its use is not worthwhile. In our cases no damage to the surrounding structures was evident. Preliminary experimental data suggest that the use of the CUSA be avoided near the brain stem or within the spinal cord. However, in a cervical ependymoma of our series, the CUSA provided complete removal of the mass without complications. This result was achieved by using lower vibratory power: we were thus able to remove pathologic soft tissue without clinically evident damage to the surrounding structures. In some particular situations the volume and the shape of the instrument can be a hindrance, and some modifications are suggested: a bayonet shape and longer tip would facilitate the reaching of deep structures and permit its use in transphenoidal surgery; incorporation of a cautery in the tip, so that contemporary hemostasis can be accomplished. Our experience indicates that the use in transphenoidal surgery; incorporation of a cautery in the tip, so that contemporary hemostasis can be accomplished. Our experience indicates that the use of the CUSA is better indicated in deep tumors: meningiomas of the base of the skull, acoustic neurinomas, pinealomas, pituitary adenomas. In gliomas it is very useful in the selective removal of the neoplastic tissue in functionally important areas.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
